ARCHIVES

Clinical Trials Approved By NCI Listed For September

This article is from The Cancer Letter archive.

Vol. 27 No. 9 | September 24, 2004

Download PDF Visit The Full Archive

Related Articles

The Cancer Letter takes two-week break; next issue Jan. 2.

December 12, 2003

FDA to refer false statements by regulated companies to SEC.

February 27, 2004

Study Examines Lung Cancer Among Lifelong Nonsmokers

October 31, 2008

ASCO Picks Charles Balch To Succeed John Durant as Executive Vice President.

January 7, 2000

Amgen Replaces “Bundling” Contract With Three Separate Contracts For Growth Factors.

September 5, 2008

Texas (Galveston) Scores Nine Points Ahead Of RPMI In Organ Systems Competitio; NCAB To Decide Award

May 4, 1984